Journal Description
COVID
COVID
is an international, peer-reviewed, open access journal on the study of coronaviruses, coronavirus-related diseases and global impact, published monthly online by MDPI.
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within ESCI (Web of Science), Scopus, CAPlus / SciFinder, and other databases.
- Journal Rank: CiteScore - Q2 (Immunology and Microbiology (miscellaneous))
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 20.6 days after submission; acceptance to publication is undertaken in 3.4 days (median values for papers published in this journal in the first half of 2025).
- Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
Impact Factor:
1.0 (2024);
5-Year Impact Factor:
1.0 (2024)
Latest Articles
A Cross-Sectional and Longitudinal Analysis of Cognitive Function and Well-Being of Older Adults in Panama During the COVID-19 Pandemic
COVID 2025, 5(8), 128; https://doi.org/10.3390/covid5080128 (registering DOI) - 7 Aug 2025
Abstract
The COVID-19 pandemic exacerbated mental illness, accelerated cognitive decline, and deepened social inequalities. In low and middle-income countries (LMIC) such as Panama, it is unclear as to whether, and to what extent, the pandemic lockdowns affected cognitive, mental, and physical health of older
[...] Read more.
The COVID-19 pandemic exacerbated mental illness, accelerated cognitive decline, and deepened social inequalities. In low and middle-income countries (LMIC) such as Panama, it is unclear as to whether, and to what extent, the pandemic lockdowns affected cognitive, mental, and physical health of older adults. This study investigated changes in cognitive function, mental health, and physical health in a sample of Panamanian older adults assessed before and during the pandemic, and examined whether sociodemographic variables were associated with cognition and mental health. Participants completed in-person interviews between 2018 and early 2020 and a follow-up telephone interview between February and May 2021. Repeated measures analyses showed no significant changes in cognitive function or depression; however, participants reported fewer chronic illnesses. Linear regression analysis indicated that higher cognitive function during the pandemic was associated with younger age, higher education, and having sufficient income. An attrition analysis compared participants who completed both interviews to those who were lost to follow-up, revealing that participants who dropped out of the study had lower socioeconomic status and greater impairment at baseline. These findings highlight the need for targeted support for vulnerable older adults during public health crises.
Full article
(This article belongs to the Special Issue COVID and Public Health)
►
Show Figures
Open AccessArticle
Mood and Anxiety in University Students During COVID-19 Isolation: A Comparative Study Between Study-Only and Study-And-Work Groups
by
Gabriel de Souza Zanini, Luana Marcela Ferreira Campanhã, Ercízio Lucas Biazus, Hugo Ferrari Cardoso and Carlos Eduardo Lopes Verardi
COVID 2025, 5(8), 127; https://doi.org/10.3390/covid5080127 - 5 Aug 2025
Abstract
The COVID-19 pandemic precipitated unprecedented social isolation measures, profoundly disrupting daily life, educational routines, and mental health worldwide. University students, already susceptible to psychological distress, encountered intensified challenges under remote learning and prolonged confinement. This longitudinal study examined fluctuations in anxiety and mood
[...] Read more.
The COVID-19 pandemic precipitated unprecedented social isolation measures, profoundly disrupting daily life, educational routines, and mental health worldwide. University students, already susceptible to psychological distress, encountered intensified challenges under remote learning and prolonged confinement. This longitudinal study examined fluctuations in anxiety and mood among 102 Brazilian university students during the pandemic, distinguishing between those solely engaged in academic pursuits and those simultaneously balancing work and study. Data collected via the Brunel Mood Scale and State-Trait Anxiety Inventory in April and July 2021 revealed that students exclusively focused on studies exhibited significant increases in depressive symptoms, anger, confusion, and anxiety, alongside diminished vigor. Conversely, participants who combined work and study reported reduced tension, fatigue, confusion, and overall mood disturbance, coupled with heightened vigor across the same period. Notably, women demonstrated greater vulnerability to anxiety and mood fluctuations, with socioeconomic disparities particularly pronounced among females managing dual roles, who reported lower family income. These findings suggest that occupational engagement may serve as a protective factor against psychological distress during crises, underscoring the urgent need for tailored mental health interventions and institutional support to mitigate the enduring impacts of pandemic-related adversities on the student population.
Full article
(This article belongs to the Section COVID Public Health and Epidemiology)
►▼
Show Figures

Figure 1
Open AccessArticle
Investigation of the P1104A/TYK2 Genetic Variant in a COVID-19 Patient Cohort from Southern Brazil
by
Giulianna Sonnenstrahl, Eduarda Sgarioni, Mayara Jorgens Prado, Marilea Furtado Feira, Renan Cezar Sbruzzi, Bibiana S. O. Fam, Alessandra Helena Da Silva Hellwig, Nathan Araujo Cadore, Osvaldo Artigalás, Alexandre da Costa Pereira, Lygia V. Pereira, Tábita Hünemeier and Fernanda Sales Luiz Vianna
COVID 2025, 5(8), 126; https://doi.org/10.3390/covid5080126 - 5 Aug 2025
Abstract
The P1104A variant in the TYK2 gene is recognized as the first common monogenic cause of tuberculosis, and recent studies also suggest a potential role in COVID-19 severity. However, its frequency and impact in admixed Latin American populations remain underexplored. Therefore, we investigated
[...] Read more.
The P1104A variant in the TYK2 gene is recognized as the first common monogenic cause of tuberculosis, and recent studies also suggest a potential role in COVID-19 severity. However, its frequency and impact in admixed Latin American populations remain underexplored. Therefore, we investigated the P1104A/TYK2 variant in a cohort comprising 1826 RT-PCR-confirmed COVID-19 patients from Southern Brazil. Cases were stratified by severity into non-severe (n = 1190) and severe (n = 636). Three homozygous individuals were identified—one non-severe and two severe cases—although no statistically significant association with disease severity was observed. The frequency of the C allele in the COVID-19 cohort (2.85%) was significantly higher than in Brazilian population databases, including “DNA do Brasil” (1.81%, p < 0.001) and ABraOM (2.34%, p = 0.03), but lower than in the multi-ancestry gnomAD database (3.71%, p = 0.01), possibly reflecting ancestry bias. We also observed associations between COVID-19 severity and sex (p = 0.003), age (p < 0.001), obesity (p < 0.001), diabetes (p < 0.001), and hypertension (p < 0.001). Future studies in larger and more diverse cohorts are needed to characterize the prevalence of the variant in admixed populations and assess its contribution to COVID-19 susceptibility.
Full article
(This article belongs to the Section Host Genetics and Susceptibility/Resistance)
Open AccessArticle
SARS-CoV-2 Infection Epidemiology Changes During Three Years of Pandemic in a Region in Central India
by
Pravin Deshmukh, Swati Bhise, Sandeep Kokate, Priyanka Mategadikar, Hina Rahangdale, Vaishali Rahangdale, Sunanda Shrikhande, Sana Pathan, Anuradha Damodare, Sachin Baghele, Juili Gajbhiye and Preeti Shahu
COVID 2025, 5(8), 125; https://doi.org/10.3390/covid5080125 - 4 Aug 2025
Abstract
Background: The surge in COVID-19 cases during the pandemic created a disease burden. An epidemiological study on COVID-19 is required as not much is known about the impact of containment and mitigation on health. We aimed to compare the epidemiological features during the
[...] Read more.
Background: The surge in COVID-19 cases during the pandemic created a disease burden. An epidemiological study on COVID-19 is required as not much is known about the impact of containment and mitigation on health. We aimed to compare the epidemiological features during the years of the COVID-19 pandemic in the Vidarbha region in Maharashtra, India, to understand the epidemiology changes throughout the pandemic’s progression. Method: All of the cases reported at our testing centers in Nagpur and its periphery during the three years of the pandemic (i.e., from February 2020 to December 2022) were included. Descriptive analyses of variables of interest and statistical measures were compared. Results: There were 537,320 tests recorded during the study period. Of these, 13,035 (13.29%), 42,909 (13.70%), and 19,936 (15.91%) tested positive in 2020, 2021, and 2022, respectively. Hospitalization decreased from 2020 to 2022. An age group shift from 45 to 16–30 years over the pandemic was noticed. Seasonally, positivity peaked in September (27.04%) in 2020, in April (43.4%) in 2021, and in January in 2022 (35.30%). The estimated case fatality ratio was highest in 2021 (36.68%) over the three years in the hospital setting. Conclusion: Understanding the changing epidemiology of SARS-CoV-2 strengthens our perceptive of this disease, which will aid in improving the healthcare system in terms of both controlling and preventing the spread of COVID-19.
Full article
(This article belongs to the Special Issue COVID and Public Health)
►▼
Show Figures

Figure 1
Open AccessArticle
Work Engagement and Compassion Fatigue Among Nursing Professionals During the COVID-19 Pandemic: A Cross-Sectional and Single-Center Study Using the ProQOL-BR and UWES-9 Scales
by
Juliana Lima da Cunha, Luciano Garcia Lourenção, José Gustavo Monteiro Penha, Francisco Rosemiro Guimarães Ximenes Neto, Daiani Modernel Xavier, Vagner Ferreira do Nascimento, Adriane Maria Netto de Oliveira, Daniela Menezes Galvão, Alberto de Oliveira Redü and Natália Sperli Geraldes Marin dos Santos Sasaki
COVID 2025, 5(8), 124; https://doi.org/10.3390/covid5080124 - 2 Aug 2025
Abstract
Objectives: This study investigated levels of work engagement and the occurrence of compassion fatigue among nursing professionals during the COVID-19 pandemic. Methods: A cross-sectional, descriptive, and correlational study was conducted at a Brazilian university hospital between February and April 2022. The Brazilian versions
[...] Read more.
Objectives: This study investigated levels of work engagement and the occurrence of compassion fatigue among nursing professionals during the COVID-19 pandemic. Methods: A cross-sectional, descriptive, and correlational study was conducted at a Brazilian university hospital between February and April 2022. The Brazilian versions of the Utrecht Work Engagement Scale (UWES-9) and the Professional Quality of Life Scale (ProQOL-BR) were administered. Results: High levels of compassion satisfaction (44.9 points), low levels of burnout (21.0 points), and low levels of secondary traumatic stress (22.8 points) were observed. No professional demonstrated a profile consistent with compassion fatigue. Engagement levels were high for dedication (5.3) and moderate for vigor (4.9), absorption (4.5), and overall engagement (4.9). Burnout showed moderate negative correlations with vigor (r = −0.611, p = 0.005) and dedication (r = −0.599, p = 0.019). Compassion satisfaction showed moderate positive correlations with vigor (r = 0.522, p < 0.001) and dedication (r = 0.572, p < 0.001). The overall engagement score was moderately and positively correlated with compassion satisfaction (r = 0.532, p < 0.001). Conclusions: This study identified high levels of work engagement, especially regarding dedication, and low levels of compassion fatigue among nursing professionals. The data suggest that even amid the emotional and physical demands imposed by the pandemic, participants preserved their emotional well-being and maintained a positive relationship with their work.
Full article
(This article belongs to the Section COVID Clinical Manifestations and Management)
Open AccessCase Report
SARS-CoV-2 and HCoV IgG Antibodies in the Breast Milk of a Postpartum SARS-CoV-2 Patient Following Bamlanivimab Administration: A Case Report
by
Guadalein Tanunliong, Christopher Condin, Ana Citlali Márquez, Susan Li, Nimrat Binning, Miriam Gibson, Brayden Griffiths, Alissa Wright, Deborah Money, Mel Krajden, Muhammad Morshed, Agatha N. Jassem, Gregory Haljan and Inna Sekirov
COVID 2025, 5(8), 123; https://doi.org/10.3390/covid5080123 - 1 Aug 2025
Abstract
Breast milk can provide passive immunity to infants, serving as a valuable source of maternal antibodies while remaining a non-invasive sample for investigating maternal immune responses. To date, no studies have evaluated SARS-CoV-2 and potentially cross-reactive HCoV antibodies in breast milk following bamlanivimab
[...] Read more.
Breast milk can provide passive immunity to infants, serving as a valuable source of maternal antibodies while remaining a non-invasive sample for investigating maternal immune responses. To date, no studies have evaluated SARS-CoV-2 and potentially cross-reactive HCoV antibodies in breast milk following bamlanivimab administration. A 36-year-old postpartum female was PCR-positive for SARS-CoV-2 four days post-delivery. Bamlanivimab was administered intravenously two days later. Breast milk was collected before bamlanivimab infusion, daily for two weeks post-infusion, then weekly until 102 days post-infusion. Mother and infant sera were collected only at 102 days post-infusion. All milk and serum samples were tested for IgG antibodies against SARS-CoV-2 and HCoV. We observed two distinct SARS-CoV-2 antibody peaks at days 3 and 29 post-infusion, likely representing bamlanivimab transfer and the post-infection antibody response. Beta-HCoV antibodies showed two peaks at days 6 and 29, potentially representing backboosted beta-HCoV responses and/or antibody cross-reactivity with SARS-CoV-2. Infant seropositivity for SARS-CoV-2 102 days post-infusion may represent antibodies from passive transfer via breastfeeding or a subclinical infection. This case highlights the value of breast milk as a non-invasive and repeatable sample to help understand maternal immune responses post-infection, exogenous antibody infusion, and passive antibody transfer during breastfeeding, which can provide insights into maternal–infant health research.
Full article
(This article belongs to the Section COVID Clinical Manifestations and Management)
►▼
Show Figures

Figure 1
Open AccessArticle
Hesitant Minds in Vulnerable Times: COVID-19 Vaccine Hesitancy Among University Students in Ukraine
by
Prince Yeboah, Afraa Razouk, Philip Skotzke, Werner Pitsch, Olena Chubuchna, Victoria Serhiyenko, Nataliia Slyvka, Serhii Holota, Muhammad Jawad Nasim, Ahmad Yaman Abdin and Claus Jacob
COVID 2025, 5(8), 122; https://doi.org/10.3390/covid5080122 - 31 Jul 2025
Abstract
COVID-19 vaccine hesitancy (VH), like attitudes towards other vaccines, is a critical global public health concern. Despite numerous studies covering psychological, sociodemographic, and other determinants of vaccine acceptance, resistance, and hesitance, few studies have reported these factors among students, particularly in politically unstable
[...] Read more.
COVID-19 vaccine hesitancy (VH), like attitudes towards other vaccines, is a critical global public health concern. Despite numerous studies covering psychological, sociodemographic, and other determinants of vaccine acceptance, resistance, and hesitance, few studies have reported these factors among students, particularly in politically unstable settings like Ukraine. This cross-sectional, descriptive, and quantitative study assesses hesitancy towards COVID-19 vaccines, utilizing the 5Cs Model. Among 936 respondents surveyed in 2023, 64% received at least one shot of the COVID-19 vaccine (acceptant), 11% were still considering getting vaccinated (hesitant), and 25% refused vaccination (resistant). Vaccination behavior is significantly associated with the 5Cs. Higher collective responsibility significantly increased acceptance and reduced resistance, while higher constraints lowered the chances of being either acceptant or resistant. Confidence protected against resistance. Complacency, counterintuitively, reduced odds of resistance, pointing to differences between passive hesitancy and active refusal. Male gender and sources of information and misinformation influenced confidence. Collective responsibility was positively associated with official sources and negatively with conspiracy beliefs. Complacency increased with official sources, while constraints and calculation were least explained by predictors. Practical barriers should be tackled through improved accessibility and fostering collective responsibility via targeted communication strategies. These findings provide actionable insights for policymakers, healthcare providers, and academic institutions to enhance vaccine uptake among university students, particularly in crisis settings.
Full article
(This article belongs to the Special Issue COVID and Public Health)
►▼
Show Figures

Figure 1
Open AccessReview
Autoantibodies in COVID-19: Pathogenic Mechanisms and Implications for Severe Illness and Post-Acute Sequelae
by
Lais Alves do-Nascimento, Nicolle Rakanidis Machado, Isabella Siuffi Bergamasco, João Vitor da Silva Borges, Fabio da Ressureição Sgnotto and Jefferson Russo Victor
COVID 2025, 5(8), 121; https://doi.org/10.3390/covid5080121 - 30 Jul 2025
Abstract
The COVID-19 pandemic, caused by SARS-CoV-2, has led to a wide range of acute and chronic disease manifestations. While most infections are mild, a significant number of patients develop severe illness marked by respiratory failure, thromboinflammation, and multi-organ dysfunction. In addition, post-acute sequelae—commonly
[...] Read more.
The COVID-19 pandemic, caused by SARS-CoV-2, has led to a wide range of acute and chronic disease manifestations. While most infections are mild, a significant number of patients develop severe illness marked by respiratory failure, thromboinflammation, and multi-organ dysfunction. In addition, post-acute sequelae—commonly known as long-COVID—can persist for months. Recent studies have identified the emergence of diverse autoantibodies in COVID-19, including those targeting nuclear antigens, phospholipids, type I interferons, cytokines, endothelial components, and G-protein-coupled receptors. These autoantibodies are more frequently detected in patients with moderate to severe disease and have been implicated in immune dysregulation, vascular injury, and persistent symptoms. This review examines the underlying immunological mechanisms driving autoantibody production during SARS-CoV-2 infection—including molecular mimicry, epitope spreading, and bystander activation—and discusses their functional roles in acute and post-acute disease. We further explore the relevance of autoantibodies in maternal–fetal immunity and comorbid conditions such as autoimmunity and cancer, and we summarize current and emerging therapeutic strategies. A comprehensive understanding of SARS-CoV-2-induced autoantibodies may improve risk stratification, inform clinical management, and guide the development of targeted immunomodulatory therapies.
Full article
(This article belongs to the Section Host Genetics and Susceptibility/Resistance)
►▼
Show Figures

Figure 1
Open AccessArticle
Assessment of SARS-CoV-2 Infection, Vaccination, and Immunity Status Among a Population of Dentists/Academic Professors in a Clinical Setting: One-Year Findings
by
Patricia Manarte-Monteiro, Gabriella Marques, Dina Alves, Mary Duro, Joana Domingues, Sandra Gavinha, Lígia Pereira da Silva and Liliana Teixeira
COVID 2025, 5(8), 120; https://doi.org/10.3390/covid5080120 - 28 Jul 2025
Abstract
Background: This study aimed to assess the prevalence of SARS-CoV-2 infection, vaccination, and immune status among a population, both Dentists and University Professors, within a clinical setting at one and at 12 months after COVID-19 vaccination. Methods: A cross-sectional study involving 47 professionals
[...] Read more.
Background: This study aimed to assess the prevalence of SARS-CoV-2 infection, vaccination, and immune status among a population, both Dentists and University Professors, within a clinical setting at one and at 12 months after COVID-19 vaccination. Methods: A cross-sectional study involving 47 professionals (aged 27–52) was conducted in the University Fernando Pessoa. Participants completed an online survey on SARS-CoV-2 infection status and vaccination, received and provided plasma samples for serological analysis. The protocol was approved by the UFP-Ethics Committee. Anti-S1-RBD SARS-CoV-2 IgM and IgG antibody titration values (AU/mL) were measured, by enzyme-linked-immunosorbent assay (ELISA), with reactive immunoglobulins (Ig) seropositivity for values ≥1 AU/mL. Results: SARS-CoV-2 infection rate increased from 8.5% in July 2021 to 48.9% in June 2022, with 8.5% experiencing reinfection. Vaccination rate was 91.5% by July 2021 and increased slightly to 93.6% by June 2022; 72.3% of the sample received a third dose. IgG seropositivity increased from 91.5% to 95.7% in June 2022. After one-year, significant associations were found between IgG seropositivity and both participant’s age (p = 0.009; <50 years) and vaccine doses (p = 0.003; 1–3 doses) received. Conclusions: SARS-CoV-2 infection rate, vaccination, and IgG seropositivity rates were high and increased over one year. The age and vaccination status were associated with the immunity status at 12th month follow-up. Findings highlight variability in IgG seroprevalence due to multiple influencing factors, which justifies future studies.
Full article
(This article belongs to the Section COVID Clinical Manifestations and Management)
Open AccessArticle
The Impact of COVID-19 on People Living with HIV: A Network Science Perspective
by
Jared Christopher, Aiden Nelson, Paris Somerville, Simran Patel and John Matta
COVID 2025, 5(8), 119; https://doi.org/10.3390/covid5080119 - 28 Jul 2025
Abstract
People living with HIV (PLWH) faced diverse challenges during the COVID-19 pandemic, including disruptions to care, housing instability, emotional distress, and economic hardship. This study used graph-based clustering methods to analyze pandemic-era experiences of PLWH in a national sample from the NIH’s All
[...] Read more.
People living with HIV (PLWH) faced diverse challenges during the COVID-19 pandemic, including disruptions to care, housing instability, emotional distress, and economic hardship. This study used graph-based clustering methods to analyze pandemic-era experiences of PLWH in a national sample from the NIH’s All of Us dataset (n = 242). Across three graph configurations we identified consistent subgroups shaped by social connectedness, housing stability, emotional well-being, and engagement with preventive behaviors. Comparison with an earlier local study of PLWH in Illinois confirmed recurring patterns of vulnerability and resilience while also revealing additional national-level subgroups not observed in the smaller sample. Subgroups with strong social or institutional ties were associated with greater emotional stability and proactive engagement with COVID-19 preventive behaviors, while those facing isolation and structural hardship exhibited elevated distress and limited engagement with COVID-19 preventive measures. These findings underscore the importance of precision public health strategies that reflect the heterogeneity of PLWH and suggest that strengthening social support networks, promoting housing stability, and leveraging institutional connections may enhance pandemic preparedness and HIV care in future public health crises.
Full article
(This article belongs to the Section COVID Public Health and Epidemiology)
►▼
Show Figures

Figure 1
Open AccessArticle
The Role of Gubernatorial Affiliation, Risk Perception, and Trust in COVID-19 Vaccine Hesitancy in the United States
by
Ammina Kothari, Stephanie A. Godleski and Gerit Pfuhl
COVID 2025, 5(8), 118; https://doi.org/10.3390/covid5080118 - 28 Jul 2025
Abstract
Background/Objectives: Vaccine hesitancy is becoming an increasing concern, leading to preventable outbreaks of infectious diseases. During the COVID-19 pandemic, the United States served as an intriguing case study for exploring how risk perception and trust in health authorities, including scientists, are influenced by
[...] Read more.
Background/Objectives: Vaccine hesitancy is becoming an increasing concern, leading to preventable outbreaks of infectious diseases. During the COVID-19 pandemic, the United States served as an intriguing case study for exploring how risk perception and trust in health authorities, including scientists, are influenced by government policies and how these factors affect vaccine hesitancy. Methods: We conducted a secondary analysis using the MIT COVID-19 Survey dataset to investigate whether risk perception and trust differ between states governed by Democratic or Republican governors. Results: Our analysis (n = 6119) found that participants did not vary significantly by state political affiliation in terms of their sociodemographic factors (such as age, gender, self-rated health, education, and whether they live in a city, town, or rural area), their perceived risk for the community, or their ability to control whether they become infected. However, there was a difference in the perceived risk of infection, which was higher in states governed by Republicans. Trust also varied by gubernatorial affiliation, with higher levels of trust reported among residents of Democratic-leaning states. We also found a strong mediation effect of trust on vaccine hesitancy, but this was not the case for risk perception. Conclusion: Therefore, it appears that vaccine acceptance relies on trust in health authorities, which is influenced by governmental policies. State officials should work with local health officials to build trust and increase timely responses to public health crises.
Full article
(This article belongs to the Section COVID Public Health and Epidemiology)
►▼
Show Figures

Figure 1
Open AccessArticle
Resilience or Retreat? The Impact of COVID-19 on Entrepreneurial Intentions of Undergraduate Business Students
by
Anas Al-Fattal and Michael Martin
COVID 2025, 5(8), 117; https://doi.org/10.3390/covid5080117 - 26 Jul 2025
Abstract
The COVID-19 pandemic fundamentally disrupted assumptions about entrepreneurship, career planning, and professional development. This study explored how the pandemic influenced the entrepreneurial intentions of undergraduate business students in the United States. Using a qualitative methodology based on in-depth interviews with 31 students at
[...] Read more.
The COVID-19 pandemic fundamentally disrupted assumptions about entrepreneurship, career planning, and professional development. This study explored how the pandemic influenced the entrepreneurial intentions of undergraduate business students in the United States. Using a qualitative methodology based on in-depth interviews with 31 students at a public Midwestern university, the research interpreted student narratives through the lenses of effectuation theory, resilience theory, and the theory of planned behavior. Findings revealed that many participants reframed entrepreneurship as a strategy for navigating economic uncertainty and enhancing personal agency. Students reported valuing adaptability, resourcefulness, and opportunity recognition, often experimenting with side hustles during the pandemic as a means of resilience. Their entrepreneurial thinking shifted from purely economic motivations toward aspirations for flexibility, self-fulfillment, and purposeful work. The study highlights the formative role of crisis contexts in shaping entrepreneurial identity among emerging professionals. It suggests that entrepreneurship education should move beyond traditional models, fostering skills for navigating complexity and building resilience. In doing so, the findings contribute to broader conversations about youth entrepreneurship, post-pandemic career development, and the evolving demands of the labor market in times of disruption.
Full article
(This article belongs to the Section COVID Public Health and Epidemiology)
►▼
Show Figures

Figure 1
Open AccessArticle
Dynamic Relationship Between High D-Dimer Levels and the In-Hospital Mortality Among COVID-19 Patients: A Moroccan Study
by
Bouchra Benfathallah, Abdellatif Boutagayout, Abha Cherkani Hassani, Hassan Ihazmade, Redouane Abouqal and Laila Benchekroun
COVID 2025, 5(8), 116; https://doi.org/10.3390/covid5080116 - 26 Jul 2025
Abstract
This study included 221 patients with COVID-19 who were admitted to the emergency department of Avicenne Hospital in Rabat between August 2020 and August 2021. Patients were divided into three groups according to their D-dimer levels (<1, 1–2, and >2 µg/mL). Adjusted and
[...] Read more.
This study included 221 patients with COVID-19 who were admitted to the emergency department of Avicenne Hospital in Rabat between August 2020 and August 2021. Patients were divided into three groups according to their D-dimer levels (<1, 1–2, and >2 µg/mL). Adjusted and unadjusted logistic regression analyses were performed to assess the association between elevated D-dimer levels and in-hospital mortality. Pearson’s correlation analysis was performed to explore the relationship between D-dimer levels and various biological and clinical parameters. The results revealed a statistically significant difference in the mean (SD) age among the three groups (p = 0.006). Analysis showed a statistically significant difference in the means (SD) of oxygen saturation, duration of hospital stay, and breathing rate among the three independent groups of COVID-19 patients. Patients with elevated D-dimer levels (greater than 2 µg/mL) experienced worse outcomes than those in the other groups, with severity, transfer to intensive care, and in-hospital mortality of 55 (40.7%), 35 (16%), and 24 (11%) patients, respectively, with p-values of 0.048, 0.002, and 0.002, respectively. Patients in the D-dimer > 2 µg/mL group had significantly higher C-reactive protein (CRP), lactate dehydrogenase, urea, cardiac troponin, B-type natriuretic peptide, and ferritin levels than those in the other two groups. The p-value was significant among the three groups (p = 0.044, p = 0.001, and p < 0.001). Age and elevated D-dimer levels (greater than 2 µg/mL) were associated with mortality in patients diagnosed with COVID-19. Correlation analysis indicated that D-dimer in COVID-19 patients is associated with worsening respiratory, hepatic, cardiac, and coagulation parameters, suggesting their utility as an integrative marker of disease severity. D-dimer levels > 2 µg/mL were identified as an independent risk factor for COVID-19 in-hospital mortality. Measuring and monitoring D-dimer levels can assist clinicians in taking timely actions and predicting the prognosis of patients with COVID-19.
Full article
(This article belongs to the Section COVID Clinical Manifestations and Management)
Open AccessBrief Report
Risk of SARS-CoV-2 Infection Among Hospital-Based Healthcare Workers in Thailand at Myanmar Border, 2022
by
Narumol Sawanpanyalert, Nuttagarn Chuenchom, Meng-Yu Chen, Peangpim Tantilipikara, Suchin Chunwimaleung, Tussanee Nuankum, Yuthana Samanmit, Brett W. Petersen, James D. Heffelfinger, Emily Bloss, Somsak Thamthitiwat and Woradee Lurchachaiwong
COVID 2025, 5(8), 115; https://doi.org/10.3390/covid5080115 - 25 Jul 2025
Abstract
Background: This study examined risk factors for syndrome novel coronavirus 2 virus (SARS-CoV-2) infection and self-reported adherence to infection prevention and control (IPC) measures among healthcare workers (HCWs) at a hospital in Thailand near the Myanmar border. Methods: From March to July 2022,
[...] Read more.
Background: This study examined risk factors for syndrome novel coronavirus 2 virus (SARS-CoV-2) infection and self-reported adherence to infection prevention and control (IPC) measures among healthcare workers (HCWs) at a hospital in Thailand near the Myanmar border. Methods: From March to July 2022, HCWs aged ≥ 18 with COVID-19 exposure at Mae Sot General Hospital completed a questionnaire on IPC adherence, training, and COVID-19 knowledge. Nasopharyngeal samples were collected bi-weekly for SARS-CoV-2 testing. A mobile application was used for real-time monitoring of daily symptoms and exposure risks. Chi-square, Fisher’s exact tests, and log-binomial regression were performed to investigate association. Results: Out of 289 (96.3%) participants, 27 (9.9%) tested positive for SARS-CoV-2, with cough reported by 85.2% of cases. Nurse assistants (NAs) had a higher risk of infection (adjusted relative risk [aRR] 3.87; 95% CI: 0.96–15.6). Working in inpatient departments (aRR 2.37; 95% CI: 1.09–5.15) and COVID-19 wards (aRR 5.97; 95% CI: 1.32–26.9) was also associated with increased risk. While 81.7% reported consistent hand hygiene, 37% indicated inadequate IPC knowledge. Conclusions: HCWs, especially NAs and those in high-risk departments, should receive enhanced IPC training. Real-time digital monitoring tools can enhance data collection and HCW safety and are likely to be useful tools for supporting surveillance and data collection efforts.
Full article
(This article belongs to the Section COVID Clinical Manifestations and Management)
►▼
Show Figures

Figure 1
Open AccessArticle
Treatment Times and In-Hospital Mortality Among Patients with ST-Elevation Myocardial Infarction Throughout the Waves of the COVID-19 Pandemic: Lessons Learned
by
Jessica K. Zègre-Hemsey, Abhinav Goyal, Remy Poudel, Kathie Thomas, Murtuza J. Ali, Patricia Best, Mark Bieniarz, Gregg C. Fonarow, William French, Christopher B. Granger, Timothy D. Henry, Haoyun Hong, James Jollis, Michael Redlener, Travis Spier, Harper Stone, Feras Wahab, Lanjing Wang and Alice K. Jacobs
COVID 2025, 5(8), 114; https://doi.org/10.3390/covid5080114 - 25 Jul 2025
Abstract
Previous studies about the COVID-19 pandemic on STEMI patient outcomes have conflicting results. It remains unclear if this may be attributed to regional differences and/or differences during COVID-19 wave periods. Using the American Heart Association Get With The Guidelines–Coronary Artery Disease registry data,
[...] Read more.
Previous studies about the COVID-19 pandemic on STEMI patient outcomes have conflicting results. It remains unclear if this may be attributed to regional differences and/or differences during COVID-19 wave periods. Using the American Heart Association Get With The Guidelines–Coronary Artery Disease registry data, we evaluated (1) time metrics related to STEMI system goals and (2) regional variation in STEMI incidence and in-hospital mortality during pandemic wave time periods. The study included all patients 18–100 years old admitted with STEMI (n = 72,516) to 1 of 435 American Heart Association Get With The Guidelines–Coronary Artery Disease hospitals (1 October 2019–31 December 2021). Of these, 70.8% were male and 73.0% non-Hispanic White, with a median age of 63 (IQR 18) years. Compared to pre-pandemic time frames, patients with STEMI had a higher risk profile, delayed time to treatment, were treated with fibrinolytic therapy or primary PCI, and were transferred for primary PCI at similar rates, and had higher adjusted in-hospital mortality (during the second wave in the South and Midwest). Preservation of STEMI systems of care resulted in an overall lower in-hospital mortality rate than predicted, although opportunities exist to improve treatment delays. Regional differences in mortality rates require further study.
Full article
(This article belongs to the Special Issue Cardiovascular Effects of COVID-19: Acute and Chronic)
►▼
Show Figures

Figure 1
Open AccessArticle
Perceptions Toward COVID-19 Vaccines and Factors Associated with COVID-19 Vaccine Acceptance in Peshawar, Pakistan
by
Shiromi M. Perera, Stephanie C. Garbern, Ghazi Khan, Khalid Rehman, Emma R. Germano, Asad Ullah, Javed Ali, Bhisham Kotak and Zawar Ali
COVID 2025, 5(8), 113; https://doi.org/10.3390/covid5080113 - 23 Jul 2025
Abstract
COVID-19 vaccine hesitancy in Pakistan is a barrier to optimal vaccine uptake and has been situated within a context of hesitancy towards other vaccines. A mixed-methods study was conducted during the initial COVID-19 vaccine roll-out in 2021 in four union councils in Peshawar,
[...] Read more.
COVID-19 vaccine hesitancy in Pakistan is a barrier to optimal vaccine uptake and has been situated within a context of hesitancy towards other vaccines. A mixed-methods study was conducted during the initial COVID-19 vaccine roll-out in 2021 in four union councils in Peshawar, consisting of a cross-sectional survey, eight focus group discussions (FGDs) with community members and eight in-depth interviews with healthcare workers (HCWs) to assess perceptions toward vaccines. Multivariable logistic regression was used to assess factors associated with COVID-19 vaccine hesitancy. Of 400 survey participants, 57.3% were vaccine acceptant and 42.8% vaccine hesitant. Just over half (56.8%) perceived COVID-19 vaccines to be safe. Most (88%) reported trust in HCWs to provide accurate vaccine information. FGDs revealed that women received less information about the vaccine compared to men and cultural restrictions were barriers even for those willing to be vaccinated. Correlates of vaccine acceptance included male sex (aOR 2.25; 95% CI 1.29–3.91), age 50 years or greater (aOR 1.74; 95% CI 1.19–6.31), social network support (e.g., vaccine acceptance among an individual’s social network) in receiving COVID-19 vaccines (aOR 2.38; 95% CI 1.45–3.89), community concern about COVID-19 spread (aOR 2.84; 95% CI 1.73–4.66), and trust in HCWs to provide vaccine information (aOR 3.47; 95% CI 1.62–7.42). Future vaccine promotion should prioritize engaging community leaders, sharing transparent information, combatting misinformation and rumors, and implementing household-based interventions especially targeting the importance of vaccination among women and young people to increase uptake.
Full article
(This article belongs to the Section COVID Public Health and Epidemiology)
Open AccessArticle
sCD40L-Mediated Platelet Activation and Thromboinflammation During SARS-CoV-2 Infection: Clinical and Experimental Evidence
by
Afaf Allaoui, Farah Atifi, Meryem Mabrouk, Zineb Ourradi, Abir Chami, Salma Labied, Mounia Ammara, Abdallah Naya and Younes Zaid
COVID 2025, 5(8), 112; https://doi.org/10.3390/covid5080112 - 22 Jul 2025
Abstract
Soluble CD40 ligand (sCD40L) is a molecule known for its thromboinflammatory properties and may act as a biomarker for platelet activation. Platelets are the principal producers of sCD40L, which is recognized for its impact on platelet function. However, its contribution to the platelet
[...] Read more.
Soluble CD40 ligand (sCD40L) is a molecule known for its thromboinflammatory properties and may act as a biomarker for platelet activation. Platelets are the principal producers of sCD40L, which is recognized for its impact on platelet function. However, its contribution to the platelet hyperreactivity observed in SARS-CoV-2 infection remains poorly understood. During viral infection, platelets function as crucial intermediaries, engaging with both viruses and leukocytes; and serve as a substantial source of inflammatory mediators, promoting thromboinflammation and immunothrombosis. While platelet hyperactivation is associated with the severity and mortality of COVID-19, the precise function of sCD40L in this setting remains inadequately defined. This study examined the role of platelet-derived sCD40L in platelet activation, aggregation, and thrombosis associated with COVID-19. Platelets from blood samples of 160 patients—102 with non-severe cases and 58 with severe cases—demonstrated heightened activation and aggregation, as well as elevated sCD40L release. In a mouse thrombosis model, sCD40L intensified thrombus development. These findings underscore the essential function of platelet-derived sCD40L in the pathophysiology of COVID-19 and endorse the therapeutic potential of targeting CD40L-mediated pathways to mitigate thromboinflammatory consequences.
Full article
(This article belongs to the Section COVID Clinical Manifestations and Management)
►▼
Show Figures

Figure 1
Open AccessArticle
Fear of Dying and Catastrophic Thinking Are Associated with More Severe Post-Traumatic Stress Symptoms Following COVID-19 Infection
by
Antonina D. S. Pavilanis, Lara El-Zein, Wenny Fan, Heewon Jang, Emma Leroux and Michael J. L. Sullivan
COVID 2025, 5(7), 111; https://doi.org/10.3390/covid5070111 - 18 Jul 2025
Abstract
Numerous investigations have revealed elevated rates of post-traumatic stress symptoms (PTSS) following COVID-19 infection. This study examined the relation between illness-related and psychosocial variables in the severity of PTSS in individuals previously infected with COVID-19. The study sample included 381 individuals who had
[...] Read more.
Numerous investigations have revealed elevated rates of post-traumatic stress symptoms (PTSS) following COVID-19 infection. This study examined the relation between illness-related and psychosocial variables in the severity of PTSS in individuals previously infected with COVID-19. The study sample included 381 individuals who had been infected with COVID-19 within the previous 4 months. Participants completed online measures of infection symptom severity, ongoing COVID-19 symptom burden, fear of dying and catastrophic thinking. Age, infection severity, ongoing COVID-19 symptom burden, and fear of dying and catastrophic thinking were significant correlates of the severity of PTSS. Hierarchical regression analysis revealed that age, gender, ongoing COVID-19 symptom burden, fear of dying and catastrophic thinking each made unique significant contributions to the prediction of the severity of PTSS. The results of the present study suggest that fear of dying and catastrophic thinking about COVID-19 symptoms might contribute to the development of PTSS following COVID-19 infection. Interventions aimed at reducing death fears and modifying negative and alarmist appraisals of COVID-19 symptoms might contribute to more positive recovery outcomes in individuals who are infected with COVID-19. The cross-sectional design of this study precludes statements about causality, and conclusions about temporal relations among variables must await replication in a longitudinal design.
Full article
(This article belongs to the Section COVID Clinical Manifestations and Management)
Open AccessArticle
Pancreatic Stone Protein and C-Reactive Protein as Biomarkers of Infection in ICU COVID-19 Patients: A LASSO-Based Predictive Study
by
Gabriele Melegari, Federica Arturi, Fabio Gazzotti, Elisabetta Bertellini, Benedetta Berselli, Francesca Coppi, Enrico Giuliani and Alberto Barbieri
COVID 2025, 5(7), 110; https://doi.org/10.3390/covid5070110 - 14 Jul 2025
Abstract
Background: Bacterial infections are frequent complications in critically ill COVID-19 patients, and are associated with increased morbidity, antibiotic use, and healthcare burden. Early and accurate identification of infection remains challenging. Pancreatic Stone Protein (PSP) has emerged as a promising biomarker of infection. In
[...] Read more.
Background: Bacterial infections are frequent complications in critically ill COVID-19 patients, and are associated with increased morbidity, antibiotic use, and healthcare burden. Early and accurate identification of infection remains challenging. Pancreatic Stone Protein (PSP) has emerged as a promising biomarker of infection. In this study, PSP was evaluated alongside C-reactive protein (CRP). Methods: We conducted a prospective study including 105 critically ill COVID-19 patients admitted to the intensive care unit (ICU). Blood samples were collected at admission to measure PSP and CRP. A LASSO Least Absolute Shrinkage and Selection Operator (LASSO) regression model was used to identify independent predictors of proven or suspected bacterial infection. Mixed-effects models were applied to account for repeated measures and clinical confounders. Results: Among 105 patients, 57 (54%) developed bacterial infections. PSP levels were significantly higher in infected patients (median 100 ng/mL) than in non-infected patients (median 37 ng/mL, p < 0.001). CRP was also elevated in infected patients (median 125 vs. 70 mg/L, p = 0.015). The LASSO model retained PSP as the most informative predictor. In mixed-effects logistic regression, PSP remained significantly associated with infection (OR 1.017, 95% CI 1.006–1.027, p = 0.001). The AUC for PSP was 0.87. Conclusion: PSP appears to be a useful biomarker for early detection of bacterial infection in critically ill COVID-19 patients. Its integration into infection surveillance protocols could support antibiotic stewardship efforts and improve clinical decision-making.
Full article
(This article belongs to the Section COVID Clinical Manifestations and Management)
►▼
Show Figures

Figure 1
Open AccessArticle
Analysis of the Spatiotemporal Spread of COVID-19 in Bahia, Brazil: A Cluster-Based Study, 2020–2022
by
Ramon da Costa Saavedra, Rita Carvalho-Sauer, Maria Yury Travassos Ichihara, Maria da Conceição Nascimento Costa, Enio Silva Soares and Maria Gloria Teixeira
COVID 2025, 5(7), 109; https://doi.org/10.3390/covid5070109 - 13 Jul 2025
Abstract
Background: The COVID-19 pandemic progressed unevenly across the 417 municipalities of Bahia, Brazil. Pinpointing where and when risk peaked is vital for preparing for future emergencies. Methods: We performed an ecological, spatiotemporal study using COVID-19-confirmed cases in Bahia, Brazil, from January 2020 to
[...] Read more.
Background: The COVID-19 pandemic progressed unevenly across the 417 municipalities of Bahia, Brazil. Pinpointing where and when risk peaked is vital for preparing for future emergencies. Methods: We performed an ecological, spatiotemporal study using COVID-19-confirmed cases in Bahia, Brazil, from January 2020 to December 2022. A discrete Poisson space–time scan in SaTScan-identified clusters. For each cluster, we calculated relative risk (RR) and Log Likelihood Ratio, considering p < 0.05 as significant. Results: A total of 33 clusters were detected; 25 statistically significant. The largest cluster (164 municipalities; May 2020–June 2021) comprised 702,720 observed versus 338,822 expected cases (RR = 2.8). Two overlapping large clusters (185 and 136 municipalities) during January–February 2022—coinciding with Omicron circulation—showed RR > 2.0. Localized clusters reached RR > 3.0. Spatially, risk concentrated in the south, southwest, and east of the state, with isolated countryside outbreaks. Conclusions: The heterogeneous spatiotemporal dynamics of COVID-19 in Bahia underscore the value of cluster detection for targeted surveillance and resource allocation. We recommend employing statistical techniques for early detection and control, as well as conducting further studies on socioeconomic and behavioral factors.
Full article
(This article belongs to the Special Issue Airborne Transmission of Diseases in Outdoors and Indoors)
►▼
Show Figures

Figure 1
Highly Accessed Articles
Latest Books
E-Mail Alert
News
Topics

Conferences
Special Issues
Special Issue in
COVID
How COVID-19 and Long COVID Changed Individuals and Communities 2.0
Guest Editors: Chiara Lorini, Mirko Duradoni, Andrea Guazzini, Guglielmo Bonaccorsi, Letizia MaterassiDeadline: 31 August 2025
Special Issue in
COVID
Microwave Sensors and Artificial Intelligence for Non-contact, Safe and Fast Monitoring of Human Body
Guest Editor: Sandra CostanzoDeadline: 31 August 2025
Special Issue in
COVID
New Antivirals against Coronaviruses
Guest Editor: Nadine AlvarezDeadline: 1 September 2025
Special Issue in
COVID
Exploring Neuropathology in the Post-COVID-19 Era
Guest Editor: Rodrigo Portes UreshinoDeadline: 30 November 2025